Who we are

Innoprot, established in 2007 as a spin-off from the University of the Basque Country, is a leading biotechnology company specializing in the provision of cutting-edge products and technologies for multiplexing cell-based assays in drug discovery and development. Our offerings encompass a diverse range of solutions, including primary cells, immortalized cell lines, and recombinant cell lines.

Distinguished by a proprietary technology for G protein-coupled receptor (GPCR) screening, Innoprot excels in identifying compounds of the utmost efficacy while mitigating undesired side effects. Our commitment to advancing research in the pharmaceutical industry is underscored by our innovative approach to drug discovery.

In addition to our product offerings, Innoprot functions as a Contract Research Organization (C.R.O.), delivering comprehensive screening services with a specialized focus on GPCRs, Fibrosis, and Neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, and ALS.

At Innoprot, our dedicated team brings together a wealth of experience in drug discovery technologies and a robust track record as pharmaceutical services providers. We are steadfast in our pursuit of excellence, contributing to the advancement of scientific endeavors in the field.